Skip to content
drillr.ai
Sign up

CTXR

Citius Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.59
−2.38%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+7.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 23, 2025Mazur Leonard L · director, officer: Chief Executive OfficerA-Award125,490$29
Sep 23, 2025Mazur Leonard L · director, officer: Chief Executive OfficerA-Award89,388$19
Aug 12, 2025HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award31,373$29
Aug 12, 2025HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award22,344$19
Nov 12, 2024Webb Carol · directorA-Award125,000$0.38
Nov 12, 2024Smith Robert Joseph · directorA-Award125,000$0.38
Nov 12, 2024Bartushak Jaime · officer: Chief Financial OfficerA-Award350,000$0.38
Nov 12, 2024Mazur Leonard L · director, 10 percent owner, officer: Chief Executive OfficerA-Award600,000$0.38
Nov 12, 2024Czuczman Myron · officer: Chief Medical OfficerA-Award300,000$0.38
Nov 12, 2024Dutia Suren G · directorA-Award125,000$0.38
Nov 12, 2024MCGRATH DENNIS M · directorA-Award125,000$0.38
Nov 12, 2024HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award350,000$0.38
Nov 12, 2024HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award75,000$0.38
Nov 12, 2024Holuka Eugene Myron · directorA-Award125,000$0.38
Sep 27, 2024HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award784,314$1.15
Sep 27, 2024HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award558,597$0.77
Sep 27, 2024Mazur Leonard L · director, 10 percent owner, officer: Chief Executive OfficerA-Award3,137,255$1.15
Sep 27, 2024Mazur Leonard L · director, 10 percent owner, officer: Chief Executive OfficerA-Award2,234,700$0.77
Aug 30, 2024Holuka Eugene Myron · directorM-Exempt2,415$0.01
Aug 30, 2024Holuka Eugene Myron · directorF-InKind48$0.75
Aug 30, 2024Webb Carol · directorM-Exempt12,071$0.01
Aug 30, 2024Webb Carol · directorF-InKind236$0.77
Apr 5, 2024Mazur Leonard L · director, 10 percent owner, officer: Chief Executive OfficerA-Award1,165,048$1.42
Apr 5, 2024HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award129,450$1.42
Mar 18, 2024Smith Robert Joseph · directorA-Award75,000$0.69
Oct 12, 2023Webb Carol · directorA-Award75,000$0.70
Oct 12, 2023Czuczman Myron · officer: Chief Medical OfficerA-Award300,000$0.70
Oct 12, 2023HOLUBIAK MYRON Z · director, officer: Vice ChairmanA-Award400,000$0.70
Oct 12, 2023Holuka Eugene Myron · directorA-Award75,000$0.70
Oct 12, 2023MCGRATH DENNIS M · directorA-Award75,000$0.70
Institutional positioning

13F filings over the trailing two quarters

New 9Increased 7Reduced 8Sold out 38
FilerActionSharesFiled
GEODE CAPITAL MANAGEMENT, LLCIncreased246,158May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position167,738May 15, 2026
CITADEL ADVISORS LLCIncreased124,910Sep 2, 2026
VANGUARD FIDUCIARY TRUST CONew Position77,755May 8, 2026
BLACKROCK, INC.Unchanged69,851May 13, 2026
HRT FINANCIAL LPNew Position60,332May 14, 2026
Asset Advisory Group, Inc.Unchanged59,011Apr 16, 2026
UBS GROUP AGReduced55,025May 5, 2026
JANE STREET GROUP, LLCIncreased46,423May 12, 2026
NORTHERN TRUST CORPUnchanged43,974May 14, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced36,838May 15, 2026
CITADEL ADVISORS LLCReduced29,100May 15, 2026
LPL FINANCIAL LLCReduced25,045May 6, 2026
STATE STREET CORPUnchanged23,271May 15, 2026
XTX TOPCO LTDReduced21,295May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 23, 2025